Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RDNT · against 224 other Healthcare companies of similar size
Ranked #145 of 225 · scores higher than 35% of peers
Bars: peers in each 10-point band of the valuation score32 peers with a valuation score of 40–49, including RDNT · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | RDNT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 222 reported | -0.4% | 2.4% | 29% | 30% | |
| EBITDA yieldHigher is better · 223 reported | 3.7% | 4.5% | 44% | 50% | |
| Free cash flow yieldHigher is better · 125 reported | 1.3% | 1.1% | 52% | 20% | |
| Book yieldHigher is better · 224 reported | 19.0% | 24.4% | 42% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 3 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 5 | 22.0B CNY (≈$3.1B) | 96 | 67 | |
| 137 | 5.9B USD | 44 | 39 | |
| 143 | 40.3B SEK (≈$4.0B) | 43 | 79 | |
| 143 | 4.6B USD | 43 | 65 | |
| 145 | 5.1B USD | 42 | 52 | |
| 145 | 5.8B USD | 42 | 38 | |
| 145 | 303.5B INR (≈$3.6B) | 42 | 47 | |
| 148 | 64.1B CNY (≈$9.0B) | 41 | 48 | |
| 148 | 7.7B USD | 41 | 37 | |
| 148 | 593.2B INR (≈$7.1B) | 41 | 47 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score